 | | | | French President Emmanuel Macron said on Wednesday it was possible the COVID-19 vaccine would eventually be made compulsory in France, but said it was not the priority for now. | | | | | | Eagle Pharmaceuticals Inc said on Wednesday the U.S. health regulator approved its generic version of Endo International's blood pressure drug, Vasostrict, sending its shares to a more than one-month high. | | | | | | France on Wednesday registered 65,713 new coronavirus infections during the last 24 hours, data from the health ministry showed, pushing the seven-days moving average of new infections over 50,000, the highest value since Nov. 2020. | | | | | | The Delta variant of the coronavirus is still predominant in Italy, the National Health Institute (ISS) said on Wednesday, releasing data of a flash-survey showing it accounted for more than 99% of cases on Dec. 6. | | | | | | Doctor Ruxandra Divan, an intensive care anaesthetist in eastern France, slumped down onto her haunches against a wall of her department, exhausted by the prospect of tackling a new COVID-19 wave with a depleted staff. | | | | | | A boisterous line of families snaked through the corridors of Madrid's Infanta Sofia hospital on Wednesday as hundreds of keen parents sought to get their children vaccinated on the day Spain opened up COVID-19 shots for five- to 11-year-olds. | | | | | | England's Chief Medical Officer Chris Whitty said on Wednesday that the Omicron coronavirus variant posed a really serious threat and that what health officials already knew about was "bad". | | | | | | Six-year-old Johanna squeezed her eyes shut as she received her first coronavirus vaccine on Wednesday at the Bethesda children's hospital in the Hungarian capital Budapest. | | | | | | Hospitalisation rates are rising in some areas in Britain as the Omicron coronavirus variant sparks a wave of new infections, England's top health official said on Wednesday as he warned the number of cases would break records in the next few weeks. | | | | | | BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test, an early signal that booster shots could be key to protection against infection from the newly identified variant. | | | | | |
